Wednesday, December 20, 2017

From Iran To CEO Of A Biotech Startup, Bioniz, With No Revenue But A $400 Million Valuation

Nazli Azimi founded Bioniz Therapeutics, where she's developing new types of drugs to fight cancer and autoimmune diseases like celiac and alopecia. Her theory: attack so-called cytokines, the multiple proteins that block immune pathways.

from Forbes Real Time https://www.forbes.com/sites/forbestreptalks/2017/12/20/from-iran-to-ceo-of-a-biotech-startup-bioniz-with-no-revenue-but-a-400-million-valuation/
via IFTTT

No comments:

Post a Comment